PT1741443E - Combinação de vacinas para a meningite b/c - Google Patents

Combinação de vacinas para a meningite b/c Download PDF

Info

Publication number: PT1741443E
Authority: PT; Portugal
Prior art keywords: meningitidis; combination; vaccines; serogroup; oligosaccharides
Prior art date: 1998-05-29

Application number

PT60766474T

Other languages

English (en)

Inventor

Dan M Granoff

Bjorn Haneberg

Johan Holst

Howard Raff

Ingeborg Aaberge

Original Assignee

Novartis Vaccines & Diagnostic

Norwegian Inst Of Public Health

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-05-29

Filing date

1999-05-28

Publication date

2014-07-31

1999-05-28 Application filed by Novartis Vaccines & Diagnostic, Norwegian Inst Of Public Health filed Critical Novartis Vaccines & Diagnostic

2014-07-31 Publication of PT1741443E publication Critical patent/PT1741443E/pt

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/831—Drug, bio-affecting and body treating compositions involving capsular polysaccharide of bacterium, e.g. polyribosyl ribitol phosphate
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Mycology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Fats And Perfumes (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Beans For Foods Or Fodder (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PT60766474T 1998-05-29 1999-05-28 Combinação de vacinas para a meningite b/c PT1741443E (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US8735198P	1998-05-29	1998-05-29
US10644698P	1998-10-30	1998-10-30

Publications (1)

Publication Number	Publication Date
PT1741443E true PT1741443E (pt)	2014-07-31

Family

ID=26776879

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PT99926046T PT1079857E (pt)	1998-05-29	1999-05-28	Combinação de vacinas para a meningite b e c
PT60766474T PT1741443E (pt)	1998-05-29	1999-05-28	Combinação de vacinas para a meningite b/c

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PT99926046T PT1079857E (pt)	1998-05-29	1999-05-28	Combinação de vacinas para a meningite b e c

Country Status (15)

Country	Link
US (1)	US8007815B1 (pt)
EP (2)	EP1079857B1 (pt)
JP (2)	JP5074644B2 (pt)
AT (1)	ATE346609T1 (pt)
AU (2)	AU761495B2 (pt)
BR (1)	BR9910749A (pt)
CA (1)	CA2332963C (pt)
CY (1)	CY1107550T1 (pt)
DE (1)	DE69934225T2 (pt)
DK (1)	DK1079857T3 (pt)
ES (2)	ES2485940T3 (pt)
HK (1)	HK1034460A1 (pt)
NZ (1)	NZ508771A (pt)
PT (2)	PT1079857E (pt)
WO (1)	WO1999061053A1 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001500738A (ja)	1996-09-17	2001-01-23	カイロンコーポレイション	細胞内疾患を処置するための組成物および方法
CA2332963C (en)	1998-05-29	2013-07-23	Chiron Corporation	Combination meningitidis b/c vaccines
AU783894B2 (en)	1999-05-19	2005-12-22	Novartis Vaccines And Diagnostics S.R.L.	Combination neisserial compositions
GB9928196D0 (en) *	1999-11-29	2000-01-26	Chiron Spa	Combinations of B, C and other antigens
ES2588917T3 (es) *	2000-01-17	2016-11-07	Glaxosmithkline Biologicals Sa	Vacuna de VME suplementada contra meningococo
US6936261B2 (en)	2000-07-27	2005-08-30	Children's Hospital & Research Center At Oakland	Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
GB0115176D0 (en)	2001-06-20	2001-08-15	Chiron Spa	Capular polysaccharide solubilisation and combination vaccines
WO2003010194A2 (en)	2001-07-27	2003-02-06	Chiron Srl.	Meningococcus adhesins nada, app and orf 40
MX339524B (es)	2001-10-11	2016-05-30	Wyeth Corp	Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
GB0316560D0 (en)	2003-07-15	2003-08-20	Chiron Srl	Vesicle filtration
US8765135B2 (en) *	2003-10-02	2014-07-01	Novartis Ag	Liquid vaccines for multiple meningococcal serogroups
GB0419627D0 (en)	2004-09-03	2004-10-06	Chiron Srl	Immunogenic bacterial vesicles with outer membrane proteins
GB0424092D0 (en)	2004-10-29	2004-12-01	Chiron Srl	Immunogenic bacterial vesicles with outer membrane proteins
LT2682126T (lt)	2005-01-27	2017-02-27	Children`s Hospital & Research Center at Oakland	Gna1870 pagrindu gaminamos pūslelių pavidalo vakcinos, skirtos plataus spektro apsaugai nuo neisseria meningitidis sukeltų ligų
EP2200642B1 (en)	2007-10-19	2012-04-18	Novartis AG	Meningococcal vaccine formulations
CN102596240B (zh) *	2009-08-27	2015-02-04	诺华股份有限公司	包括脑膜炎球菌fHBP序列的杂交多肽
WO2012025873A2 (en)	2010-08-23	2012-03-01	Wyeth Llc	STABLE FORMULATIONS OF NEISSERIA MENINGITIDIS rLP2086 ANTIGENS
US9259462B2 (en)	2010-09-10	2016-02-16	Glaxosmithkline Biologicals Sa	Developments in meningococcal outer membrane vesicles
NZ607224A (en)	2010-09-10	2014-11-28	Wyeth Llc	Non-lipidated variants of neisseria meningitidis orf2086 antigens
GB201015132D0 (en) *	2010-09-10	2010-10-27	Univ Bristol	Vaccine composition
SA115360586B1 (ar)	2012-03-09	2017-04-12	فايزر انك	تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
US8986710B2 (en)	2012-03-09	2015-03-24	Pfizer Inc.	Neisseria meningitidis compositions and methods thereof
AU2013311702A1 (en) *	2012-09-06	2015-02-19	Novartis Ag	Combination vaccines with serogroup B meningococcus and D/T/P
EP4056198A3 (en)	2012-09-18	2022-12-07	GlaxoSmithKline Biologicals SA	Outer membrane vesicles
WO2014136064A2 (en)	2013-03-08	2014-09-12	Pfizer Inc.	Immunogenic fusion polypeptides
KR20210002757A (ko)	2013-09-08	2021-01-08	화이자 인코포레이티드	나이세리아 메닌지티디스 조성물 및 그의 방법
MX2017010705A (es)	2015-02-19	2017-12-04	Pfizer	Composiciones de neisseria meningitidis y metodos de la misma.
CN110234658B (zh)	2017-01-31	2024-03-12	辉瑞大药厂	脑膜炎奈瑟菌组合物及其使用方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2848965A1 (de)	1978-11-11	1980-05-22	Behringwerke Ag	Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
US4707543A (en) *	1985-09-17	1987-11-17	The United States Of America As Represented By The Secretary Of The Army	Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines
US7118757B1 (en) *	1988-12-19	2006-10-10	Wyeth Holdings Corporation	Meningococcal class 1 outer-membrane protein vaccine
AU640118B2 (en) *	1988-12-19	1993-08-19	De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur	Meningococcal class 1 outer-membrane protein vaccine
JPH0832638B2 (ja)	1989-05-25	1996-03-29	カイロンコーポレイション	サブミクロン油滴乳剤を含んで成るアジュバント製剤
DE69423383T2 (de)	1993-05-13	2000-08-24	American Cyanamid Co., Wayne	Herstellung und Verwendungen von LOS-verminderten Aussenmembran-Proteinen von Gram-negativen Kokken
WO1995029662A2 (en)	1994-04-20	1995-11-09	U.S. Department Of The Army	Vaccine against gram-negative bacterial infections
US6180111B1 (en)	1995-05-18	2001-01-30	University Of Maryland	Vaccine delivery system
US6476201B1 (en) *	1995-09-18	2002-11-05	Id Biomedical Corporation Of Quebec	Methods for the production of non-covalently complexed and multivalent proteosome sub-unit vaccines
DE19601754A1 (de) *	1996-01-19	1997-07-24	Hoechst Ag	Dictyocaulus viviparus Antigen zur Diagnose des Lungenwurmbefalls und zur Vakzinierung
US5846735A (en) *	1996-04-18	1998-12-08	University Of Iowa Research Foundation	Hepatitis C virus Fc-binding function
ATE208629T1 (de) *	1996-08-27	2001-11-15	Chiron Corp	Neisseria meningitidis serogruppe b glykokonjugate und verfahren zu deren verwendung
US6558677B2 (en) *	1996-10-15	2003-05-06	Wendell D. Zollinger	Vaccine against gram negative bacteria
EP0994723A1 (en) *	1997-06-24	2000-04-26	Chiron Corporation	Methods of immunizing adults using anti-meningococcal vaccine compositions
BR9811475A (pt) *	1997-07-17	2000-08-15	North American Vaccine Inc	Conjugados imunogênicos compreendendo uma porina meningocóccica de grupo b e um polissacarìdeo de h. influenzae
GB9727262D0 (en)	1997-12-24	1998-02-25	Smithkline Beecham Biolog	Vaccine
CA2332963C (en)	1998-05-29	2013-07-23	Chiron Corporation	Combination meningitidis b/c vaccines
WO2001034642A2 (en)	1999-11-12	2001-05-17	University Of Iowa Research Foundation	Control of neisserial membrane synthesis
US6936261B2 (en)	2000-07-27	2005-08-30	Children's Hospital & Research Center At Oakland	Vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
GB0220194D0 (en)	2002-08-30	2002-10-09	Chiron Spa	Improved vesicles
PT1587537E (pt)	2003-01-30	2012-05-30	Novartis Ag	Vacinas injetáveis contra múltiplos serogrupos meningocócicos
GB0316560D0 (en)	2003-07-15	2003-08-20	Chiron Srl	Vesicle filtration
US8765135B2 (en)	2003-10-02	2014-07-01	Novartis Ag	Liquid vaccines for multiple meningococcal serogroups

1999
- 1999-05-28 CA CA2332963A patent/CA2332963C/en not_active Expired - Fee Related
- 1999-05-28 AU AU42215/99A patent/AU761495B2/en not_active Revoked
- 1999-05-28 EP EP99926046A patent/EP1079857B1/en not_active Expired - Lifetime
- 1999-05-28 EP EP20140169154 patent/EP2796148A3/en not_active Withdrawn
- 1999-05-28 PT PT99926046T patent/PT1079857E/pt unknown
- 1999-05-28 BR BR9910749-0A patent/BR9910749A/pt not_active Application Discontinuation
- 1999-05-28 DK DK99926046T patent/DK1079857T3/da active
- 1999-05-28 DE DE69934225T patent/DE69934225T2/de not_active Expired - Lifetime
- 1999-05-28 JP JP2000550512A patent/JP5074644B2/ja not_active Expired - Fee Related
- 1999-05-28 WO PCT/US1999/011977 patent/WO1999061053A1/en active IP Right Grant
- 1999-05-28 NZ NZ508771A patent/NZ508771A/en not_active IP Right Cessation
- 1999-05-28 US US09/701,453 patent/US8007815B1/en not_active Expired - Fee Related
- 1999-05-28 ES ES06076647.4T patent/ES2485940T3/es not_active Expired - Lifetime
- 1999-05-28 ES ES99926046T patent/ES2278446T3/es not_active Expired - Lifetime
- 1999-05-28 PT PT60766474T patent/PT1741443E/pt unknown
- 1999-05-28 AT AT99926046T patent/ATE346609T1/de active
2001
- 2001-07-20 HK HK01105114A patent/HK1034460A1/xx not_active IP Right Cessation
2003
- 2003-09-02 AU AU2003244518A patent/AU2003244518A1/en not_active Withdrawn
2007
- 2007-01-31 CY CY20071100128T patent/CY1107550T1/el unknown
2009
- 2009-09-24 JP JP2009219818A patent/JP2009292851A/ja active Pending

Also Published As

Publication number	Publication date
CA2332963C (en)	2013-07-23
DE69934225D1 (de)	2007-01-11
JP5074644B2 (ja)	2012-11-14
EP1079857B1 (en)	2006-11-29
AU4221599A (en)	1999-12-13
JP2002516292A (ja)	2002-06-04
WO1999061053A1 (en)	1999-12-02
ATE346609T1 (de)	2006-12-15
US8007815B1 (en)	2011-08-30
CA2332963A1 (en)	1999-12-02
NZ508771A (en)	2003-08-29
ES2278446T3 (es)	2007-08-01
AU761495B2 (en)	2003-06-05
DK1079857T3 (da)	2007-01-29
HK1034460A1 (en)	2001-10-26
JP2009292851A (ja)	2009-12-17
EP2796148A3 (en)	2015-02-25
ES2485940T3 (es)	2014-08-14
EP1079857A1 (en)	2001-03-07
AU2003244518A1 (en)	2003-09-25
BR9910749A (pt)	2001-02-13
EP2796148A2 (en)	2014-10-29
DE69934225T2 (de)	2007-09-27
PT1079857E (pt)	2007-02-28
CY1107550T1 (el)	2013-03-13

Publication	Publication Date	Title
HK1034460A1 (en)	2001-10-26	Combination meningitidis b/c vaccines
NO20022531L (no)	2002-07-12	Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer
DE122011000003I1 (de)	2011-05-05	Neisseria meningitidis Kombinationimpfstoffe
IL245955A0 (en)	2016-07-31	Immunogenic preparations for the prevention and treatment of inflammatory bowel disease
HUP0302636A2 (hu)	2003-11-28	Hasított burkolt víruskészítmény
PT998287E (pt)	2003-09-30	Utilizacao de levobupivacaina
HUP9801266A2 (hu)	1998-08-28	Multimer, rekombináns ureázvakcina
EP1741443A3 (en)	2007-02-28	Combination meningitidis B/C vaccines
ATE334697T1 (de)	2006-08-15	Boviner atmungs- und darmcoronavirus als impfstoff
EP2364726A3 (en)	2011-11-09	Vaccine against neisseria infection
EP0673633A3 (de)	1995-11-29	Ärztlicher oder zahnärztlicher Behandlungsstuhl.
UA18990A (uk)	1997-12-25	Зубhий імплаhтат
NZ523676A (en)	2003-03-28	Use of cetyl myristate and cetyl palmitate to treat irritable bowel syndrome or irritable bowel disease